Cambridge Trust’s Dorman Products DORM Stock Holding History

Cambridge Trust’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41	Closed	-$3K	–	770
2022 Q4	$3K	Buy	+41	New	+$3.48K	﹤0.01%	743

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Cambridge Trust's DORM Position: Q1 2023 in Review

Cambridge Trust sold out of Dorman Products (DORM) in Q1 2023, closing a stake of 41 shares — an estimated $3K sold.

Cambridge Trust first reported a position in DORM in Q4 2022 and held it in 1 quarter. The position peaked at $3K in Q4 2022. 238 funds tracked by Wall St. Rank hold DORM as of Q1 2023.

Cambridge Trust reported no remaining Dorman Products position as of Q1 2023 after selling out during the quarter.
Cambridge Trust sold 41 Dorman Products shares in Q1 2023, an estimated $3K.
Cambridge Trust first reported a position in Dorman Products in Q4 2022 and held it in 1 quarter.
Cambridge Trust's Dorman Products position peaked at $3K in Q4 2022.
238 funds tracked by Wall St. Rank held Dorman Products as of Q1 2023.

Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.